Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
CXSL2101261 | ASC22注射液 | envafolimab | Injection | Biological Products(1) | New Drug Application | 2021-08-13 | Ascletis Biological Technology(Hangzhou) Co Ltd | view |